+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Contract Research Organization Market - Global Forecast to 2030- Product Image
Contract Research Organization Market - Global Forecast to 2030- Product Image
New

Contract Research Organization Market - Global Forecast to 2030

  • PDF Icon

    Report

  • 192 Pages
  • May 2025
  • Region: Global, United States
  • 360iResearch™
  • ID: 6085407
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Executive Summary: Setting the Stage for the CRO Market

The contract research organization (CRO) sector has emerged as a cornerstone of the life sciences industry, enabling pharmaceutical and biotechnology companies to accelerate development timelines, manage complex regulatory pathways, and optimize resource allocation. Fueled by escalating R&D expenditures, expanding outsourcing mandates, and rising demand for specialized expertise, the industry has evolved into a vibrant ecosystem where innovation and collaboration converge. In this dynamic environment, stakeholders must navigate shifting paradigms-from the integration of digital trial platforms and real-world evidence generation to heightened regulatory scrutiny and cost containment pressures. As the marketplace matures, CROs are challenged to differentiate through expanded service portfolios, strategic partnerships, and advanced analytics capabilities. This executive summary offers a concise yet thorough overview of the forces shaping the CRO landscape, examines the implications of recent policy measures such as the 2025 US tariffs, and distills key insights from segmentation, regional, and competitor analyses. By synthesizing these elements, decision-makers will gain a clear framework for aligning investment strategies, optimizing operational models, and fostering sustainable competitive advantage in a rapidly transforming industry.

Transformative Shifts Redefining the Contract Research Landscape

In recent years, the CRO landscape has undergone transformative shifts driven by digital innovation, strategic realignments, and evolving stakeholder expectations. Decentralized and hybrid trial designs have proliferated, leveraging telemedicine, mobile health applications, and remote monitoring devices to enhance patient engagement and data quality. Artificial intelligence and machine learning tools are being adopted to streamline protocol design, accelerate patient recruitment, and predict safety signals with greater precision. Simultaneously, regulatory frameworks across major markets have tightened, prompting providers to invest in compliance infrastructure and real-world evidence capabilities to support post-approval commitments. Partnerships between sponsors and specialized CROs are now emphasizing co-development models, intellectual property co-ownership, and risk-sharing arrangements to accelerate go-to-market timelines. Moreover, there is a growing emphasis on therapeutic specialization, as niche providers carve out leadership in areas such as gene therapy, immuno-oncology, and rare diseases. These shifts underscore the imperative for CROs to cultivate agility, scale digital and analytic competencies, and strategically align service offerings with the emerging needs of sponsors and patients alike.

Assessing the Cumulative Impact of US Tariffs in 2025

The introduction of new US tariffs in 2025 has reverberated across the CRO sector, amplifying supply chain costs and impacting the procurement of raw materials, laboratory reagents, and clinical trial devices. CROs dependent on imported diagnostic kits, preclinical assay components, and specialized manufacturing inputs have experienced margin compression, compelling service providers to reassess supplier networks and explore nearshoring opportunities. Higher import duties on therapeutic device components have translated into increased trial budgets, while fluctuations in foreign exchange rates have further complicated cost forecasting. In response, many CROs are optimizing inventory strategies, negotiating long-term supply agreements with tier-one vendors, and investing in local manufacturing partnerships to mitigate tariff impacts. Sponsors are also recalibrating their outsourcing strategies, favoring integrated service providers that can absorb tariff-related cost variances. Ultimately, navigating the cumulative effect of 2025 US tariffs requires a balanced approach that combines strategic sourcing, pricing flexibility, and transparent communication with clients to preserve both service quality and financial performance.

Key Segmentation Insights Shaping Service and Therapeutic Dynamics

The CRO market’s complexity is reflected in its multi-dimensional segmentation, each offering unique growth drivers and competitive dynamics. Based on service types, the market encompasses Clinical Services-with Phase I, Phase II, Phase III, and Phase IV trial management-Post-Market Services that include Product Evaluation, Real-World Evidence Studies, Regulatory Compliance, and Safety Monitoring, and Preclinical Services comprising In Vitro and In Vivo Studies. From a therapeutic perspective, demand spans Cardiovascular Diseases targeting Coronary Artery Disease and Heart Failure, Infectious Diseases focusing on Bacterial and Viral Infections, Neurology addressing Neurodegenerative Diseases and Seizure Disorders, and Oncology covering Hematological Malignancies and Solid Tumors. Considering output type, providers support Biologics development including Monoclonal Antibodies and Vaccines, Medical Devices segmented into Diagnostic Devices and Therapeutic Devices, and Small Molecule Drugs delivered as Injectables and Oral Solids. End-user segmentation highlights Academic Institutes engaged in Clinical Trial Partnerships and Research Collaborations, Biotechnology Companies developing Biologics and Gene Therapies, Government Organizations leading Public Health Initiatives and Regulatory Oversight, and Pharmaceutical Companies specializing in Generic and Proprietary Drugs. Development phase segmentation spans Clinical Phase with Early and Late Phase Trials, Discovery Phase encompassing Lead Optimization and Target Identification, Post-Approval Phase covering Life Cycle Management and Post-Marketing Surveillance, and Pre-Clinical Phase focused on Safety Testing and Toxicology Studies. Delivery mode segmentation includes Injection Delivery through Intramuscular and Intravenous, Oral Delivery via Capsules and Tablets, and Topical Delivery in the form of Creams and Patches. Finally, technology platform segmentation identifies Biologic Production Platforms such as Fusion Proteins and Recombinant DNA Technology, Delivery Technologies including Microsphere Technology and Nanoformulations, and Drug Discovery Technologies leveraging Computational Modeling and High-Throughput Screening.

Regional Highlights Driving CRO Demand and Growth Patterns

Regional dynamics play a pivotal role in shaping CRO strategies and growth trajectories. In the Americas, robust R&D funding, a mature regulatory environment, and a dense network of biotech clusters underpin steady demand for full-service and niche CRO offerings, while rising healthcare costs drive interest in cost-effective trial models. Europe, Middle East & Africa presents a diverse landscape where harmonized regulations in the European Union coexist with emerging markets in the Middle East and Africa; providers are focusing on regulatory expertise, multilingual capabilities, and localized patient recruitment strategies to navigate this complexity. The Asia-Pacific region has become a focal point for capacity expansion, fueled by lower operational costs, growing patient pools, and supportive government incentives in countries such as China, India, and South Korea; strategic partnerships with local CROs and investments in infrastructure are enabling sponsors to accelerate study timelines and access diverse patient populations.

Leading Industry Players and Their Strategic Footprints

Leading firms in the CRO sector have built competitive advantage through differentiated service portfolios, geographic reach, and technology investments. Charles River Laboratories International, Inc., Clinipace Worldwide, Inc., CRF Health, ICON plc, IQVIA Holdings Inc., KCR S.A., Labcorp Drug Development, Medelis, Inc., Medpace Holdings, Inc., Novotech Health Holdings Pte Ltd., Parexel International Corporation, Pivotal S.L., PPD, Inc., PRA Health Sciences, Inc., Syneos Health Inc., Worldwide Clinical Trials, Inc., and WuXi AppTec Co., Ltd. collectively illustrate the market’s breadth, operating across preclinical, clinical, and post-approval services. These providers leverage strategic acquisitions to fill capability gaps, invest in digital platforms to streamline data management, and form alliances with technology partners to enhance patient engagement tools. Regional positioning remains key, with some firms emphasizing APAC expansion and others deepening local footprints in EMEA. At the same time, a shared focus on regulatory science, real-world evidence generation, and decentralized trial solutions reflects an industry-wide pivot toward outcome-driven, patient-centric models.

Actionable Recommendations for CRO Sector Leadership

To thrive in this evolving environment, industry leaders should prioritize several strategic imperatives. First, embedding digital and decentralized trial capabilities into core offerings will enhance patient recruitment, retention, and data integrity while reducing study timelines. Second, cultivating in-house regulatory expertise and real-world evidence competencies will enable seamless navigation of complex approval pathways and bolster value propositions with payers and health authorities. Third, diversifying service portfolios through targeted partnerships or acquisitions in high-growth niches-such as cell and gene therapies, personalized medicine, and rare disease trials-will balance pipeline risk and drive margin expansion. Fourth, establishing resilient supply chain networks, including local manufacturing and reagent sourcing, will mitigate cost volatility and tariff impacts. Fifth, investing in talent development and data governance frameworks will reinforce a culture of quality, compliance, and innovation. Finally, maintaining an agile operating model and transparent client communication will foster enduring partnerships and sustain competitive differentiation.

Conclusion: Positioning for Sustainable Competitive Advantage

The CRO industry stands at an inflection point where innovation, strategic execution, and stakeholder collaboration will determine long-term success. The confluence of digital transformation, shifting regulatory landscapes, and evolving sponsor expectations demands that providers adapt quickly, leveraging advanced analytics and decentralized methodologies to deliver cost-effective, high-quality research services. Segmentation insights reveal the importance of tailoring offerings to specific service lines and therapeutic areas, while regional analysis underscores the value of localized expertise and operational agility. Key players have demonstrated that strategic M&A, technology partnerships, and a relentless focus on patient-centric outcomes can unlock new growth levers. By embracing the actionable recommendations outlined-ranging from digital trial integration to supply chain resilience-CROs can position themselves as indispensable partners in the drug and device development continuum. The path forward requires a harmonious blend of innovation, regulatory acumen, and a commitment to excellence, ensuring that the sector continues to propel breakthroughs that improve global health.

Market Segmentation & Coverage

This research report categorizes the Contract Research Organization Market to forecast the revenues and analyze trends in each of the following sub-segmentations:

  • Clinical Services
    • Phase I Trials
    • Phase II Trials
    • Phase III Trials
    • Phase IV Trials
  • Post-Market Services
    • Product Evaluation
    • Real-World Evidence Studies
    • Regulatory Compliance
    • Safety Monitoring
  • Preclinical Services
    • In Vitro Studies
    • In Vivo Studies
  • Cardiovascular Diseases
    • Coronary Artery Disease
    • Heart Failure
  • Infectious Diseases
    • Bacterial Infections
    • Viral Infections
  • Neurology
    • Neurodegenerative Diseases
    • Seizure Disorders
  • Oncology
    • Hematological Malignancies
    • Solid Tumors
  • Biologics
    • Monoclonal Antibodies
    • Vaccines
  • Medical Devices
    • Diagnostic Devices
    • Therapeutic Devices
  • Small Molecule Drugs
    • Injectables
    • Oral Solids
  • Academic Institutes
    • Clinical Trial Partnerships
    • Research Collaborations
  • Biotechnology Companies
    • Biologics Developers
    • Gene Therapy
  • Government Organizations
    • Public Health Initiatives
    • Regulatory Agencies
  • Pharmaceutical Companies
    • Generic Drugs
    • Proprietary Drugs
  • Clinical Phase
    • Early Phase Trials
    • Late Phase Trials
  • Discovery Phase
    • Lead Optimization
    • Target Identification
  • Post-Approval Phase
    • Life Cycle Management
    • Post-Marketing Surveillance
  • Pre-Clinical Phase
    • Safety Testing
    • Toxicology Studies
  • Injection Delivery
    • Intramuscular
    • Intravenous
  • Oral Delivery
    • Capsules
    • Tablets
  • Topical Delivery
    • Creams
    • Patches
  • Biologic Production Platforms
    • Fusion Proteins
    • Recombinant DNA Technology
  • Delivery Technologies
    • Microsphere Technology
    • Nanoformulations
  • Drug Discovery Technologies
    • Computational Modeling
    • High-throughput Screening

This research report categorizes the Contract Research Organization Market to forecast the revenues and analyze trends in each of the following sub-regions:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

This research report categorizes the Contract Research Organization Market to delves into recent significant developments and analyze trends in each of the following companies:

  • Charles River Laboratories International, Inc.
  • Clinipace Worldwide, Inc.
  • CRF Health
  • ICON plc
  • IQVIA Holdings Inc.
  • KCR S.A.
  • Labcorp Drug Development
  • Medelis, Inc.
  • Medpace Holdings, Inc.
  • Novotech Health Holdings Pte Ltd.
  • Parexel International Corporation
  • Pivotal S.L.
  • PPD, Inc.
  • PRA Health Sciences, Inc.
  • Syneos Health Inc.
  • Worldwide Clinical Trials, Inc.
  • WuXi AppTec Co., Ltd.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Contract Research Organization Market, by Service Types
8.1. Introduction
8.2. Clinical Services
8.2.1. Phase I Trials
8.2.2. Phase II Trials
8.2.3. Phase III Trials
8.2.4. Phase IV Trials
8.3. Post-Market Services
8.3.1. Product Evaluation
8.3.2. Real-World Evidence Studies
8.3.3. Regulatory Compliance
8.3.4. Safety Monitoring
8.4. Preclinical Services
8.4.1. In Vitro Studies
8.4.2. In Vivo Studies
9. Contract Research Organization Market, by Therapeutic Areas
9.1. Introduction
9.2. Cardiovascular Diseases
9.2.1. Coronary Artery Disease
9.2.2. Heart Failure
9.3. Infectious Diseases
9.3.1. Bacterial Infections
9.3.2. Viral Infections
9.4. Neurology
9.4.1. Neurodegenerative Diseases
9.4.2. Seizure Disorders
9.5. Oncology
9.5.1. Hematological Malignancies
9.5.2. Solid Tumors
10. Contract Research Organization Market, by Output Type
10.1. Introduction
10.2. Biologics
10.2.1. Monoclonal Antibodies
10.2.2. Vaccines
10.3. Medical Devices
10.3.1. Diagnostic Devices
10.3.2. Therapeutic Devices
10.4. Small Molecule Drugs
10.4.1. Injectables
10.4.2. Oral Solids
11. Contract Research Organization Market, by End Users
11.1. Introduction
11.2. Academic Institutes
11.2.1. Clinical Trial Partnerships
11.2.2. Research Collaborations
11.3. Biotechnology Companies
11.3.1. Biologics Developers
11.3.2. Gene Therapy
11.4. Government Organizations
11.4.1. Public Health Initiatives
11.4.2. Regulatory Agencies
11.5. Pharmaceutical Companies
11.5.1. Generic Drugs
11.5.2. Proprietary Drugs
12. Contract Research Organization Market, by Development Phase
12.1. Introduction
12.2. Clinical Phase
12.2.1. Early Phase Trials
12.2.2. Late Phase Trials
12.3. Discovery Phase
12.3.1. Lead Optimization
12.3.2. Target Identification
12.4. Post-Approval Phase
12.4.1. Life Cycle Management
12.4.2. Post-Marketing Surveillance
12.5. Pre-Clinical Phase
12.5.1. Safety Testing
12.5.2. Toxicology Studies
13. Contract Research Organization Market, by Delivery Mode
13.1. Introduction
13.2. Injection Delivery
13.2.1. Intramuscular
13.2.2. Intravenous
13.3. Oral Delivery
13.3.1. Capsules
13.3.2. Tablets
13.4. Topical Delivery
13.4.1. Creams
13.4.2. Patches
14. Contract Research Organization Market, by Technology Platforms
14.1. Introduction
14.2. Biologic Production Platforms
14.2.1. Fusion Proteins
14.2.2. Recombinant DNA Technology
14.3. Delivery Technologies
14.3.1. Microsphere Technology
14.3.2. Nanoformulations
14.4. Drug Discovery Technologies
14.4.1. Computational Modeling
14.4.2. High-throughput Screening
15. Americas Contract Research Organization Market
15.1. Introduction
15.2. Argentina
15.3. Brazil
15.4. Canada
15.5. Mexico
15.6. United States
16. Asia-Pacific Contract Research Organization Market
16.1. Introduction
16.2. Australia
16.3. China
16.4. India
16.5. Indonesia
16.6. Japan
16.7. Malaysia
16.8. Philippines
16.9. Singapore
16.10. South Korea
16.11. Taiwan
16.12. Thailand
16.13. Vietnam
17. Europe, Middle East & Africa Contract Research Organization Market
17.1. Introduction
17.2. Denmark
17.3. Egypt
17.4. Finland
17.5. France
17.6. Germany
17.7. Israel
17.8. Italy
17.9. Netherlands
17.10. Nigeria
17.11. Norway
17.12. Poland
17.13. Qatar
17.14. Russia
17.15. Saudi Arabia
17.16. South Africa
17.17. Spain
17.18. Sweden
17.19. Switzerland
17.20. Turkey
17.21. United Arab Emirates
17.22. United Kingdom
18. Competitive Landscape
18.1. Market Share Analysis, 2024
18.2. FPNV Positioning Matrix, 2024
18.3. Competitive Analysis
18.3.1. Charles River Laboratories International, Inc.
18.3.2. Clinipace Worldwide, Inc.
18.3.3. CRF Health
18.3.4. ICON plc
18.3.5. IQVIA Holdings Inc.
18.3.6. KCR S.A.
18.3.7. Labcorp Drug Development
18.3.8. Medelis, Inc.
18.3.9. Medpace Holdings, Inc.
18.3.10. Novotech Health Holdings Pte Ltd.
18.3.11. Parexel International Corporation
18.3.12. Pivotal S.L.
18.3.13. PPD, Inc.
18.3.14. PRA Health Sciences, Inc.
18.3.15. Syneos Health Inc.
18.3.16. Worldwide Clinical Trials, Inc.
18.3.17. WuXi AppTec Co., Ltd.
19. ResearchAI
20. ResearchStatistics
21. ResearchContacts
22. ResearchArticles
23. Appendix

List of Figures
FIGURE 1. CONTRACT RESEARCH ORGANIZATION MARKET MULTI-CURRENCY
FIGURE 2. CONTRACT RESEARCH ORGANIZATION MARKET MULTI-LANGUAGE
FIGURE 3. CONTRACT RESEARCH ORGANIZATION MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE TYPES, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE TYPES, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY THERAPEUTIC AREAS, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY THERAPEUTIC AREAS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY OUTPUT TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY OUTPUT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY END USERS, 2024 VS 2030 (%)
FIGURE 14. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY END USERS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DEVELOPMENT PHASE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DEVELOPMENT PHASE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DELIVERY MODE, 2024 VS 2030 (%)
FIGURE 18. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DELIVERY MODE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TECHNOLOGY PLATFORMS, 2024 VS 2030 (%)
FIGURE 20. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TECHNOLOGY PLATFORMS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. AMERICAS CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. AMERICAS CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. UNITED STATES CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 24. UNITED STATES CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. EUROPE, MIDDLE EAST & AFRICA CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 28. EUROPE, MIDDLE EAST & AFRICA CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 29. CONTRACT RESEARCH ORGANIZATION MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 30. CONTRACT RESEARCH ORGANIZATION MARKET, FPNV POSITIONING MATRIX, 2024


List of Tables
TABLE 1. CONTRACT RESEARCH ORGANIZATION MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE TYPES, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY PHASE I TRIALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY PHASE II TRIALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY PHASE III TRIALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY PHASE IV TRIALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL SERVICES, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY POST-MARKET SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY PRODUCT EVALUATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY REAL-WORLD EVIDENCE STUDIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY REGULATORY COMPLIANCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SAFETY MONITORING, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY POST-MARKET SERVICES, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY PRECLINICAL SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY IN VITRO STUDIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY IN VIVO STUDIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY PRECLINICAL SERVICES, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CORONARY ARTERY DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY HEART FAILURE, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY BACTERIAL INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY VIRAL INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY NEURODEGENERATIVE DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SEIZURE DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SOLID TUMORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY OUTPUT TYPE, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY BIOLOGICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY MEDICAL DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DIAGNOSTIC DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY THERAPEUTIC DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SMALL MOLECULE DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY INJECTABLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY ORAL SOLIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SMALL MOLECULE DRUGS, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL TRIAL PARTNERSHIPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY RESEARCH COLLABORATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY BIOLOGICS DEVELOPERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY GENE THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY GOVERNMENT ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY PUBLIC HEALTH INITIATIVES, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY REGULATORY AGENCIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY GOVERNMENT ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY GENERIC DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY PROPRIETARY DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 70. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2030 (USD MILLION)
TABLE 71. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL PHASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 72. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY EARLY PHASE TRIALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 73. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY LATE PHASE TRIALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 74. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL PHASE, 2018-2030 (USD MILLION)
TABLE 75. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DISCOVERY PHASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 76. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY LEAD OPTIMIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 77. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TARGET IDENTIFICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 78. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DISCOVERY PHASE, 2018-2030 (USD MILLION)
TABLE 79. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY POST-APPROVAL PHASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 80. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY LIFE CYCLE MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 81. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY POST-MARKETING SURVEILLANCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 82. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY POST-APPROVAL PHASE, 2018-2030 (USD MILLION)
TABLE 83. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY PRE-CLINICAL PHASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 84. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SAFETY TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 85. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TOXICOLOGY STUDIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 86. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY PRE-CLINICAL PHASE, 2018-2030 (USD MILLION)
TABLE 87. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 88. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY INJECTION DELIVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 89. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 90. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 91. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY INJECTION DELIVERY, 2018-2030 (USD MILLION)
TABLE 92. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY ORAL DELIVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 93. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CAPSULES, BY REGION, 2018-2030 (USD MILLION)
TABLE 94. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TABLETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 95. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY ORAL DELIVERY, 2018-2030 (USD MILLION)
TABLE 96. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TOPICAL DELIVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 97. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CREAMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 98. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY PATCHES, BY REGION, 2018-2030 (USD MILLION)
TABLE 99. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TOPICAL DELIVERY, 2018-2030 (USD MILLION)
TABLE 100. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TECHNOLOGY PLATFORMS, 2018-2030 (USD MILLION)
TABLE 101. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY BIOLOGIC PRODUCTION PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 102. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY FUSION PROTEINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 103. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY RECOMBINANT DNA TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 104. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY BIOLOGIC PRODUCTION PLATFORMS, 2018-2030 (USD MILLION)
TABLE 105. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DELIVERY TECHNOLOGIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 106. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY MICROSPHERE TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 107. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY NANOFORMULATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 108. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DELIVERY TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 109. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY TECHNOLOGIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 110. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY COMPUTATIONAL MODELING, BY REGION, 2018-2030 (USD MILLION)
TABLE 111. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY HIGH-THROUGHPUT SCREENING, BY REGION, 2018-2030 (USD MILLION)
TABLE 112. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 113. AMERICAS CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE TYPES, 2018-2030 (USD MILLION)
TABLE 114. AMERICAS CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL SERVICES, 2018-2030 (USD MILLION)
TABLE 115. AMERICAS CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY POST-MARKET SERVICES, 2018-2030 (USD MILLION)
TABLE 116. AMERICAS CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY PRECLINICAL SERVICES, 2018-2030 (USD MILLION)
TABLE 117. AMERICAS CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 118. AMERICAS CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2030 (USD MILLION)
TABLE 119. AMERICAS CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 120. AMERICAS CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 121. AMERICAS CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 122. AMERICAS CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY OUTPUT TYPE, 2018-2030 (USD MILLION)
TABLE 123. AMERICAS CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 124. AMERICAS CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 125. AMERICAS CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SMALL MOLECULE DRUGS, 2018-2030 (USD MILLION)
TABLE 126. AMERICAS CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 127. AMERICAS CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
TABLE 128. AMERICAS CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 129. AMERICAS CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY GOVERNMENT ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 130. AMERICAS CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 131. AMERICAS CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2030 (USD MILLION)
TABLE 132. AMERICAS CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL PHASE, 2018-2030 (USD MILLION)
TABLE 133. AMERICAS CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DISCOVERY PHASE, 2018-2030 (USD MILLION)
TABLE 134. AMERICAS CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY POST-APPROVAL PHASE, 2018-2030 (USD MILLION)
TABLE 135. AMERICAS CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY PRE-CLINICAL PHASE, 2018-2030 (USD MILLION)
TABLE 136. AMERICAS CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 137. AMERICAS CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY INJECTION DELIVERY, 2018-2030 (USD MILLION)
TABLE 138. AMERICAS CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY ORAL DELIVERY, 2018-2030 (USD MILLION)
TABLE 139. AMERICAS CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TOPICAL DELIVERY, 2018-2030 (USD MILLION)
TABLE 140. AMERICAS CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TECHNOLOGY PLATFORMS, 2018-2030 (USD MILLION)
TABLE 141. AMERICAS CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY BIOLOGIC PRODUCTION PLATFORMS, 2018-2030 (USD MILLION)
TABLE 142. AMERICAS CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DELIVERY TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 143. AMERICAS CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 144. AMERICAS CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 145. ARGENTINA CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE TYPES, 2018-2030 (USD MILLION)
TABLE 146. ARGENTINA CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL SERVICES, 2018-2030 (USD MILLION)
TABLE 147. ARGENTINA CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY POST-MARKET SERVICES, 2018-2030 (USD MILLION)
TABLE 148. ARGENTINA CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY PRECLINICAL SERVICES, 2018-2030 (USD MILLION)
TABLE 149. ARGENTINA CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 150. ARGENTINA CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2030 (USD MILLION)
TABLE 151. ARGENTINA CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 152. ARGENTINA CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 153. ARGENTINA CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 154. ARGENTINA CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY OUTPUT TYPE, 2018-2030 (USD MILLION)
TABLE 155. ARGENTINA CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 156. ARGENTINA CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 157. ARGENTINA CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SMALL MOLECULE DRUGS, 2018-2030 (USD MILLION)
TABLE 158. ARGENTINA CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 159. ARGENTINA CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
TABLE 160. ARGENTINA CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 161. ARGENTINA CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY GOVERNMENT ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 162. ARGENTINA CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 163. ARGENTINA CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2030 (USD MILLION)
TABLE 164. ARGENTINA CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL PHASE, 2018-2030 (USD MILLION)
TABLE 165. ARGENTINA CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DISCOVERY PHASE, 2018-2030 (USD MILLION)
TABLE 166. ARGENTINA CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY POST-APPROVAL PHASE, 2018-2030 (USD MILLION)
TABLE 167. ARGENTINA CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY PRE-CLINICAL PHASE, 2018-2030 (USD MILLION)
TABLE 168. ARGENTINA CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 169. ARGENTINA CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY INJECTION DELIVERY, 2018-2030 (USD MILLION)
TABLE 170. ARGENTINA CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY ORAL DELIVERY, 2018-2030 (USD MILLION)
TABLE 171. ARGENTINA CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TOPICAL DELIVERY, 2018-2030 (USD MILLION)
TABLE 172. ARGENTINA CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TECHNOLOGY PLATFORMS, 2018-2030 (USD MILLION)
TABLE 173. ARGENTINA CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY BIOLOGIC PRODUCTION PLATFORMS, 2018-2030 (USD MILLION)
TABLE 174. ARGENTINA CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DELIVERY TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 175. ARGENTINA CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 176. BRAZIL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE TYPES, 2018-2030 (USD MILLION)
TABLE 177. BRAZIL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL SERVICES, 2018-2030 (USD MILLION)
TABLE 178. BRAZIL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY POST-MARKET SERVICES, 2018-2030 (USD MILLION)
TABLE 179. BRAZIL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY PRECLINICAL SERVICES, 2018-2030 (USD MILLION)
TABLE 180. BRAZIL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 181. BRAZIL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2030 (USD MILLION)
TABLE 182. BRAZIL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 183. BRAZIL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 184. BRAZIL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 185. BRAZIL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY OUTPUT TYPE, 2018-2030 (USD MILLION)
TABLE 186. BRAZIL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 187. BRAZIL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 188. BRAZIL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SMALL MOLECULE DRUGS, 2018-2030 (USD MILLION)
TABLE 189. BRAZIL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 190. BRAZIL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
TABLE 191. BRAZIL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 192. BRAZIL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY GOVERNMENT ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 193. BRAZIL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 194. BRAZIL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2030 (USD MILLION)
TABLE 195. BRAZIL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL PHASE, 2018-2030 (USD MILLION)
TABLE 196. BRAZIL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DISCOVERY PHASE, 2018-2030 (USD MILLION)
TABLE 197. BRAZIL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY POST-APPROVAL PHASE, 2018-2030 (USD MILLION)
TABLE 198. BRAZIL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY PRE-CLINICAL PHASE, 2018-2030 (USD MILLION)
TABLE 199. BRAZIL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 200. BRAZIL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY INJECTION DELIVERY, 2018-2030 (USD MILLION)
TABLE 201. BRAZIL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY ORAL DELIVERY, 2018-2030 (USD MILLION)
TABLE 202. BRAZIL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TOPICAL DELIVERY, 2018-2030 (USD MILLION)
TABLE 203. BRAZIL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TECHNOLOGY PLATFORMS, 2018-2030 (USD MILLION)
TABLE 204. BRAZIL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY BIOLOGIC PRODUCTION PLATFORMS, 2018-2030 (USD MILLION)
TABLE 205. BRAZIL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DELIVERY TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 206. BRAZIL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 207. CANADA CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE TYPES, 2018-2030 (USD MILLION)
TABLE 208. CANADA CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL SERVICES, 2018-2030 (USD MILLION)
TABLE 209. CANADA CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY POST-MARKET SERVICES, 2018-2030 (USD MILLION)
TABLE 210. CANADA CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY PRECLINICAL SERVICES, 2018-2030 (USD MILLION)
TABLE 211. CANADA CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 212. CANADA CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2030 (USD MILLION)
TABLE 213. CANADA CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 214. CANADA CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 215. CANADA CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 216. CANADA CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY OUTPUT TYPE, 2018-2030 (USD MILLION)
TABLE 217. CANADA CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 218. CANADA CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 219. CANADA CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SMALL MOLECULE DRUGS, 2018-2030 (USD MILLION)
TABLE 220. CANADA CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 221. CANADA CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
TABLE 222. CANADA CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 223. CANADA CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY GOVERNMENT ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 224. CANADA CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 225. CANADA CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2030 (USD MILLION)
TABLE 226. CANADA CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL PHASE, 2018-2030 (USD MILLION)
TABLE 227. CANADA CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DISCOVERY PHASE, 2018-2030 (USD MILLION)
TABLE 228. CANADA CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY POST-APPROVAL PHASE, 2018-2030 (USD MILLION)
TABLE 229. CANADA CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY PRE-CLINICAL PHASE, 2018-2030 (USD MILLION)
TABLE 230. CANADA CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 231. CANADA CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY INJECTION DELIVERY, 2018-2030 (USD MILLION)
TABLE 232. CANADA CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY ORAL DELIVERY, 2018-2030 (USD MILLION)
TABLE 233. CANADA CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TOPICAL DELIVERY, 2018-2030 (USD MILLION)
TABLE 234. CANADA CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TECHNOLOGY PLATFORMS, 2018-2030 (USD MILLION)
TABLE 235. CANADA CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY BIOLOGIC PRODUCTION PLATFORMS, 2018-2030 (USD MILLION)
TABLE 236. CANADA CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DELIVERY TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 237. CANADA CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 238. MEXICO CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE TYPES, 2018-2030 (USD MILLION)
TABLE 239. MEXICO CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL SERVICES, 2018-2030 (USD MILLION)
TABLE 240. MEXICO CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY POST-MARKET SERVICES, 2018-2030 (USD MILLION)
TABLE 241. MEXICO CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY PRECLINICAL SERVICES, 2018-2030 (USD MILLION)
TABLE 242. MEXICO CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 243. MEXICO CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2030 (USD MILLION)
TABLE 244. MEXICO CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 245. MEXICO CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 246. MEXICO CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 247. MEXICO CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY OUTPUT TYPE, 2018-2030 (USD MILLION)
TABLE 248. MEXICO CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 249. MEXICO CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 250. MEXICO CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SMALL MOLECULE DRUGS, 2018-2030 (USD MILLION)
TABLE 251. MEXICO CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 252. MEXICO CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
TABLE 253. MEXICO CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 254. MEXICO CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY GOVERNMENT ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 255. MEXICO CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 256. MEXICO CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2030 (USD MILLION)
TABLE 257. MEXICO CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL PHASE, 2018-2030 (USD MILLION)
TABLE 258. MEXICO CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DISCOVERY PHASE, 2018-2030 (USD MILLION)
TABLE 259. MEXICO CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY POST-APPROVAL PHASE, 2018-2030 (USD MILLION)
TABLE 260. MEXICO CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY PRE-CLINICAL PHASE, 2018-2030 (USD MILLION)
TABLE 261. MEXICO CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 262. MEXICO CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY INJECTION DELIVERY, 2018-2030 (USD MILLION)
TABLE 263. MEXICO CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY ORAL DELIVERY, 2018-2030 (USD MILLION)
TABLE 264. MEXICO CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TOPICAL DELIVERY, 2018-2030 (USD MILLION)
TABLE 265. MEXICO CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TECHNOLOGY PLATFORMS, 2018-2030 (USD MILLION)
TABLE 266. MEXICO CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY BIOLOGIC PRODUCTION PLATFORMS, 2018-2030 (USD MILLION)
TABLE 267. MEXICO CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DELIVERY TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 268. MEXICO CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 269. UNITED STATES CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE TYPES, 2018-2030 (USD MILLION)
TABLE 270. UNITED STATES CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL SERVICES, 2018-2030 (USD MILLION)
TABLE 271. UNITED STATES CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY POST-MARKET SERVICES, 2018-2030 (USD MILLION)
TABLE 272. UNITED STATES CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY PRECLINICAL SERVICES, 2018-2030 (USD MILLION)
TABLE 273. UNITED STATES CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 274. UNITED STATES CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2030 (USD MILLION)
TABLE 275. UNITED STATES CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 276. UNITED STATES CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 277. UNITED STATES CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 278. UNITED STATES CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY OUTPUT TYPE, 2018-2030 (USD MILLION)
TABLE 279. UNITED STATES CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 280. UNITED STATES CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 281. UNITED STATES CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SMALL MOLECULE DRUGS, 2018-2030 (USD MILLION)
TABLE 282. UNITED STATES CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 283. UNITED STATES CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
TABLE 284. UNITED STATES CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 285. UNITED STATES CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY GOVERNMENT ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 286. UNITED STATES CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 287. UNITED STATES CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2030 (USD MILLION)
TABLE 288. UNITED STATES CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL PHASE, 2018-2030 (USD MILLION)
TABLE 289. UNITED STATES CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DISCOVERY PHASE, 2018-2030 (USD MILLION)
TABLE 290. UNITED STATES CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY POST-APPROVAL PHASE, 2018-2030 (USD MILLION)
TABLE 291. UNITED STATES CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY PRE-CLINICAL PHASE, 2018-2030 (USD MILLION)
TABLE 292. UNITED STATES CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 293. UNITED STATES CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY INJECTION DELIVERY, 2018-2030 (USD MILLION)
TABLE 294. UNITED STATES CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY ORAL DELIVE

Companies Mentioned

  • Charles River Laboratories International, Inc.
  • Clinipace Worldwide, Inc.
  • CRF Health
  • ICON plc
  • IQVIA Holdings Inc.
  • KCR S.A.
  • Labcorp Drug Development
  • Medelis, Inc.
  • Medpace Holdings, Inc.
  • Novotech Health Holdings Pte Ltd.
  • Parexel International Corporation
  • Pivotal S.L.
  • PPD, Inc.
  • PRA Health Sciences, Inc.
  • Syneos Health Inc.
  • Worldwide Clinical Trials, Inc.
  • WuXi AppTec Co., Ltd.

Methodology

Loading
LOADING...

Related Topics

Related Reports

Contract Research Organizations Services Market - Global Forecast to 2030 - Product Image

Contract Research Organizations Services Market - Global Forecast to 2030

  • Report
  • 191 Pages
  • Global
From
Biopharmaceutical CMO & CRO Market - Global Forecast to 2030 - Product Image

Biopharmaceutical CMO & CRO Market - Global Forecast to 2030

  • Report
  • 181 Pages
  • Global
From
Contract Research Organization Services Market - Global Forecast to 2030 - Product Image

Contract Research Organization Services Market - Global Forecast to 2030

  • Report
  • 194 Pages
  • Global
From
Healthcare Contract Research Organization Market by Type (Full-Service Organizations, Functional Service Providers), Services (Clinical Trials, Consulting & Advisory Services, Drug Discovery), Therapeutic Area, End-User - Global Forecast 2025-2030 - Product Image

Healthcare Contract Research Organization Market by Type (Full-Service Organizations, Functional Service Providers), Services (Clinical Trials, Consulting & Advisory Services, Drug Discovery), Therapeutic Area, End-User - Global Forecast 2025-2030

  • Report
  • 185 Pages
  • Global
From
Healthcare Contract Research Organization Market Size, Share & Trends Analysis Report By Type (Drug Discovery, Pre-clinical, And Clinical), By Service, By Therapeutic Area, By Molecule, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Healthcare Contract Research Organization Market Size, Share & Trends Analysis Report By Type (Drug Discovery, Pre-clinical, And Clinical), By Service, By Therapeutic Area, By Molecule, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 200 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.